Global Injectable Drug Delivery Market

To Enquire About the Report Click Here

IndustryARC

Global Injectable Drug Delivery Market

By Devices, Therapeutics & Formulations [Self-Injection Devices (Pen, Needle Free & Auto Injectors), Auto-Immune Diseases, Diabetes, Oncology, Hormonal Disorders, Liposomes, Microspheres, Nanoparticles, Polymeric Micelles] (2015 – 2020)

To Enquire About the Report Click Here

TABLE OF CONTENTS 1. Market Overview 2. Executive Summary 3. Market Landscape 3.1. Market Share Analysis 3.2. Comparative Analysis 3.2.1.

Product Benchmarking

3.2.2.

End user profiling

3.2.3.

Patent Analysis

3.2.4.

Top 5 Financials Analysis

4. Global Injectable Drug Delivery - Market Forces 4.1. Market Drivers 4.1.1.

Inherent Use Case Scenario of IDD Devices With Biologics

4.1.2.

Increase in Global Diabetic Population and Usage of Insulin Pens

4.1.3.

Others

4.2. Market Constraints 4.2.1.

Infection Risks And Government Laws

4.2.2.

Others

4.3. Market Challenges 4.3.1.

Higher Manufacturing Standards Needed to Avoid Product Recalls

4.3.2.

Others

4.4. Attractiveness of the Industry 4.4.1.

Power of Suppliers

4.4.2.

Power of Customers

4.4.3.

Threat of New entrants

To Enquire About the Report Click Here

4.4.4.

Threat of Substitution

4.4.5.

Degree of Competition

5. Global Injectable Drug Delivery Market– Strategic Analysis 5.1. Value Chain Analysis 5.2. Opportunities Analysis 5.3. Product/Market Life Cycle Analysis 6. Global Injectable Drug Delivery Market – By Type 6.1. Pharmaceutical Drug Formulations 6.2. By Device 6.2.1.

Conventional Devices

6.2.2.

Auto Injector Devices

6.2.3.

Self-Injector Devices

6.2.4.

Pen Injectors

6.2.5.

Needle Free Injector Devices

6.3. Others 7. Global Injectable Drug Delivery Market - By Type of Diseases 7.1. Anemia 7.2. Diabetes 7.3. Multiple sclerosis 7.4. Rheumatoid 7.5. Crohn's 7.6. Others 8. Global Injectable Drug Delivery Market -Geographic Analysis 8.1. Introduction 8.2. North America

To Enquire About the Report Click Here

8.2.1.

Canada

8.2.2.

Haiti

8.2.3.

Mexico

8.2.4.

USA

8.2.5.

Others

8.3. South & Central America 8.3.1.

Argentina

8.3.2.

Brazil

8.3.3.

Chile

8.3.4.

Colombia

8.3.5.

Venezuela

8.3.6.

Others

8.4. Europe 8.4.1.

Germany

8.4.2.

France

8.4.3.

Italy

8.4.4.

Russia

8.4.5.

Spain

8.4.6.

Turkey

8.4.7.

U.K

8.4.8.

Others

8.5. APAC 8.5.1.

Bangladesh

8.5.2.

China

8.5.3.

India

To Enquire About the Report Click Here

8.5.4.

Nepal

8.5.5.

Srilanka

8.5.6.

Singapore

8.5.7.

Malaysia

8.5.8.

Others

8.6. ROW 9. Market Entropy 9.1. New Product Launches 9.2. M&As, Collaborations, JVs and Partnerships 10. Company Profiles (Overview, Financials, SWOT Analysis – Top 5 Companies, Developments, Product Portfolio) 10.1. Becton Dickinson and Company (BD) 10.2. Baxter International Inc. 10.3. Consort Medical PLC 10.4. Crossject SA 10.5. Eli Lilly and Company 10.6. Elcam Medical 10.7. Novo Nordisk 10.8. Owen Mumford Ltd 10.9. Sanofi 10.10. Schott AG 10.11. Terumo Corporation 10.12. Ypsomed Holding AG 10.13. Others 11. Appendix 11.1. Abbreviations

To Enquire About the Report Click Here

11.2. Sources 11.3. Research Methodology 11.4. Bibliography 11.5. Compilation of Expert Insights 11.6. Disclaimer

To Enquire About the Report Click Here

1. GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET OVERVIEW 1.1 REPORT SCOPE The global injectable drug delivery devices market has been analyzed with respect to the demand for devices from different countries across the globe. These markets are broken down into segments and sub-segments, providing exhaustive value analysis for the years 2010, 2011, 2012, and forecast to 2020. The drug injection devices market has been segmented into conventional injectors and selfinjection devices broadly. Similarly the drug formulations market has been segmented into the conventional drugs and novel drugs segments. The therapeutic areas are further segmented and analyzed in this report.

While conventional devices are growing at a CAGR of 7.37%, self-injection devices are expected to grow at 16.6% during 2013 – 2018. Conventional injection devices hold around 87% market share currently but this is expected to decrease to around 83% by 2018, as the use of self-injection devices increases in the next 5 years.

The global injectable drug delivery devices market is expected to increase from around $11.6bn in 2013 to around $17.5bn in 2018. Self-injection devices are expected to grow at the highest growth rate of 16.1% with conventional injection devices growing at only 7.4% during the forecast period 2013 – 2018.

Analyzing the competitive landscape of the global conventional injectable devices market for 2012 IndustryARC is of the opinion that Becton Dickinson & Co. had the top position with a market share of around 27% followed by Baxter International Inc with a share of 23%. Overall these two companies along with Terumo Corporation and Schott AG together held market share of around 85%.

To Enquire About the Report Click Here

SAMPLE DATA SAMPLE FIGURE: EUROPEAN INSULIN CARTRIDGES MARKET, BY VOLUME -3ML (MU) BY COUNTRY, 2013

Russian Federation Germany Turkey UK Italy

SAMPLE TABLE: INJECTABLE DRUG DELIVERY DEVICES - GLOBAL MARKET,

BY TYPE OF DEVICE ($ MILLION) - 2011 - 2020 Type of Device

Auto Injector Devices Conventional Devices Self-Injector Devices Pen Injectors Needle Free Injector Devices Total

2011

2012

2013

2020

CAGR (%)

xx xx 800 xx xx

xx xx 933 xx xx

xx xx 1088 xx xx

xx xx 3187 xx xx

2013-2020 xx xx 16.6 xx xx

xx

xx

xx

xx

xx

To Enquire About the Report Click Here

KEY MARKET INSIGHTS 1.

More than 50% of the new drugs will be delivered by injection in the next 10 years.

2.

Demand for Needle free injection devices which can inject drugs with minimum or no pain is expected to see strong growth in the next 5 years.

3.

Newer technologies like injectable smart sponge, electronically controlled pills, biocompatable and biodegradable hydrogels are being tested for commercial purposes and their arrival can offer better and accurate drug delivery products.

4.

Injectable biologics is a key segment driving the growth of injectable drug devices market; they are largely used for the treatment of serious medical conditions.

5.

North America and Europe together account for more than 65% of the market share of injectable drug devices market in 2013.

6.

Novo Nordisk, Eli Lilly & Sanofi-Aventis are aggressively increasing their Insulin cartridges production volumes.

To Enquire About the Report Click Here

RESEARCH METHODOLOGY The quantitative and qualitative data collected for the IDD report is from a combination of secondary and primary sources. Research interviews were conducted with senior executives and/or mangers in the IDD Industry. These Key Opinion Leaders (KOLs) were then provided a questionnaire to gather quantitative and qualitative inputs on their operations, performance, strategies and views on the overall market, including key developments and technology trends. Data from interviews is consolidated, checked for consistency and accuracy, and the final market numbers are again validated by experts. The global market was split by product types and geography based on different factors like primary and secondary sources, understanding of the number of companies operating in each segment and also KOL insights.

We have used various secondary sources such as directories, articles, white papers, newsletters, annual reports and paid databases such as OneSource, Hoovers and Factiva to identify and collect information for extensive technical and commercial study of the IDD market.

The approach towards finding information regarding the market and forecasting has been quite extensive. Since the amount of materials consumed for additive manufacturing depend almost entirely on the number of battery shipments across the world, we have taken this to be our hypothesis.. This, when combined with the Average Selling Price (ASP) of the various materials under consideration, has led us to the revenues of different segments. The market has then been forecast according to the market trend shown by the sales of major players like Maxwell Technologies Inc. (U.S.), Nesscap Co. Ltd. (South Korea), Cap-XX (Australia) Panasonic Electronic Devices Co. Ltd. (Japan) and also considering new developments.

The key players in the market and its value chain were identified through secondary research and their market opinions were also gathered in a similar way through telephonic interviews and questionnaires. We have also studied the annual reports of these top market players.

Interviews with key opinion leaders such as directors, managers, and marketing personnel were used extensively in understanding the need and emergence of IDD market.

We also have extensive database of contacts which were used to conduct primary interviews and also to get their inputs using questionnaires.

To Enquire About the Report Click Here

THE ARC ADVANTAGE An analytical model lies at the core of our process, ensuring logical consistency throughout our research. We complement the model with secondary data and interviews with industry experts to reflect the latest trends. With our final expert validation, we provide you with only the most accurate and actionable intelligence.

THE ARC PROCESS Analytical Method 1. Granular breakdown of drivers into factors 2. Validate all factors in terms of their present impact on the market 3. Assign weights to these factors in terms of their relevance and impact on the market 4. Build the Analytical Model ANALYTICAL MODEL

Base Method

1. Get a topdown estimate of the market 2. Follow it up with a bottom-up estimate of the market 3. Check forconsistency and new growth factors that are relevant over the next 10 Years

4. Build the Base model BASE MODEL

Consolidation Method 1. Granular breakdown of drivers into factors 2. Validate all factors in terms of their present impact on the market.

3. Assign weights to these factors in terms of their relevance and impact on the market.

4. Build the Consolidated Model

Delphi Verification 1. Verify the findings of the model with experts from across the value chain 2. Verify the findings with players across small and large enterprises 3. Tweak the model and add new factors 4. Finalize the ARC Model

CONSOLIDATED MODEL

ARC MODEL

To Enquire About the Report Click Here

ABOUT US IndustryARC was started by a group of young, passionate professionals along with extensively experienced industry veterans across various business segments. Our focus and expertise is mainly in the field of analytics, market research and consulting. Our singular goal is to provide accurate and affordable research to our clients.

Our research team has expertise in diverse fields like Healthcare, Chemicals, Manufacturing, Logistics, Electronics and Automotive. However diverse the expertise maybe, everyone in our team shares one common trait - we love data and we love providing solutions to clients using that data even more! Seeing your business flourish based on our solutions and strategy is what we love the most!

Industry ARC publishes more than 30 reports on an annual basis in the mentioned five Industries. Our reports are in-depth and high quality reports that can help decision makers frame better strategies for their business requirements. These reports can be further customized as per your needs.

Disclaimer: •

The reports sold by IndustryARC are limited publications containing valuable market information provided to a select group of customers in response to orders.

•

Our customers acknowledge and agree that any report bought from IndustryARC is for their own internal use and not for general publication or disclosure to third parties.

•

Our reports or part of the reports, information contained in the report, cannot be shared or resold to any other third party.

•

Disclosure to third parties, usage of data in a public document, article or blog by the customer can be done with prior permission taken from IndustryARC.

For information regarding permissions and sales, contact: sales@industryarc.com | sanjay.matthews@industryarc.com

To Enquire About the Report Click Here

IndustryARC +1 585 - 331 - 8686 sales@industryarc.com

Copyright Š 2015 IndustryARC All Rights Reserved. This document contains highly confidential information and is the sole property of IndustryARC. No part of it may be circulated, copied, quoted, or otherwise reproduced without the approval of IndustryARC.